Atherectomy Devices Market Size, Share, and Industry Analysis By Type (Instruments and Accessories), By Product Type (Directional Arthrectomy Systems, Rotational Arthrectomy Systems, and Others), By Application (Coronary Artery Disease and Peripheral Artery Disease), By End User (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast till 2032

The global atherectomy devices market is booming due to a heightened prevalence of peripheral artery diseases together with an increasing demand for minimally invasive procedures through the use of atherectomy devices by which they are enabled to endovascular procedures with plaque removal within arteries from where blood will be transferred down and to which critical limb ischemia, as perhaps an example of one of such severe fatal complications, would no longer be significant.

• The U.S. atherectomy device market is said to grow by 7.2% during the year 2023, as mentioned by the U.S. Food and Drug Administration. Along similar lines, the European Commission has stated that as of 2022, the value of the European atherectomy device market equated to around EUR 150 million, which underpins increased demand from the region.

Atherectomy devices are very useful in the treatment of PAD, most especially in the geriatric population who could have otherwise been pruned due to the risk posed by vascular diseases. In Spain, for example, according to the Spanish Ministry of Health, atherectomy treatments form part of over EUR 50 million annual costs in healthcare. It indicates the increased acceptance of these procedures among global healthcare systems.

Atherectomy Devices Market Driver

Cardiovascular Diseases And Innovations Drive Market Growth

Also, the global market for atherectomy devices is considerably triggered by the sudden rising incidence of cardiovascular diseases with concomitant invigoration of innovative advances in medical technologies. According to the Centers for Disease Control and Prevention, there are about 15 million U.S.-based adults suffering from PAD, which significantly indicates the increasing need for treatment-efficacious solutions for the disease.

Atherectomy Devices Market Restraint

High Costs And Regulations Restrict Market Growth

At the same time, market growth is restricted by expensive costs associated with atherectomy procedures, narrow reimbursement policies, as well as strict regulatory frameworks. The U.S. hospitalizations due to PAD reach nearly 400,000, which adds to the advanced cost of healthcare, according to the American College of Cardiology. These financial constraints may restrict access to atherectomy services, especially to cost-sensitive markets.

Atherectomy Devices Market Opportunity

Market Growth Driven By Infrastructure Expansion

Further opportunities for the atherectomy devices market to realize growth are reliant on improved healthcare infrastructure and further investment into novel atherectomy technologies. According to World Health Organization (WHO) expectations, the atherectomy devices market for the Middle East and Asia will surpass USD 500 million by 2025 which means, there will be a huge demand shortly.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Cardiovascular Diseases, By Key Countries
• Micro and Macro Economic Indicators
• Drivers, Restraints, Trends, and Opportunities
• Adoption of Minimally Invasive Surgeries, By Region
• Business Strategies Adopted by Key Players
• Consolidated SWOT Analysis of Key Players
• Key Industry Developments (Mergers, Acquisitions, Partnerships)
• Overview: Regulatory and Reimbursement Scenario

Analysis by Type

By type, the market is divided into instruments and accessories.

The instruments segment is anticipated to be the largest segment of the market owing to their essential use in atherectomy procedures and constant technological advancements leading to increased precision and efficiency. Increasing inclination toward minimally invasive procedures will also drive segment growth.

Due to the growing adoption of atherectomy procedures, accessories such as guidewires, catheters, and such components will register high growth in the coming years. Its growth is further driven by a growing emphasis on procedural efficiency and safety.

Analysis by Product Type

By product type, the market is divided into directional arthrectomy systems, rotational arthrectomy systems, and others.

The directional atherectomy systems segment is projected to dominate the market for Atherectomy Devices during the forecast period, owing to its ability to specifically eliminate plaque with minimal damage to the healthy vessel walls. Its expansion is also favored by the increasing shift towards targeted treatment strategies.

The effectiveness of rotational atherectomy systems to treat heavily calcified lesions is expected to boost the growth of these systems over the forecast period. Growing uptake in complicated circumstances, as well as developing device design, are driving market growth.

Analysis by Application

By application, the market is divided into coronary artery disease and peripheral artery disease.

The coronary artery disease segment holds the largest market share, owing to the high prevalence of coronary artery disease, and the growing adoption of atherectomy devices for localized plaque removal. Increasing preference for less invasive procedures to propel growth.

The segment for peripheral artery disease is expected to witness remarkable growth dost, primarily from rising awareness, increasing incidence of peripheral arterial blockages, and the emergence of atherectomy devices enhancing treatment outcomes.

Analysis by End User

By end user, the market is divided into hospitals & ASCs, specialty clinics, and others.

Due to the high number of procedures performed and the availability of advanced medical infrastructure, the Hospitals & ASCs are anticipated to hold a prominent market share. The increasing shift toward outpatient procedures in ASCs also assists the growth of this segment.

Due to the increased use of atherectomy devices in specialized cardiovascular centers, the specialty clinics segment is expected to witness significant growth during the forecast period. Growth is also driven by increasing patient preference for differentiated care.

Regional Analysis

Based on geography, the market has been studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

To gain extensive insights into the market, Download for Customization

It is expected that North America would offer the maximum growth for the Atherectomy Devices Market as it comprises huge healthcare expenditure and established a well-prescribed medical infrastructure. According to the National Institutes of Health, the country's figure is 12% for people above 60 years old with PAD; therefore, it is highly for atherectomy devices' use.

Then, Europe is also powerfully influencing growth in this market with a (growing) older population and a considerable budget increase to all functional levels of the health system. 65% of patients with PAD have been documented as having signs of intermittent claudication by the European Society of Vascular Surgery.

Asia Pacific is probably the fastest growing market for atherectomy devices, considering the increased public awareness of health, with a similarly enhanced window for access to advanced treatments. According to ICMR, Peripheral Artery Disease accounts for 10-15% of deaths associated with cardiovascular diseases in India. Thus, this needs adequate remedy in this part of the world.

Key Players Covered

The report includes the profiles of the following key players:

• Boston Scientific Corporation (U.S.)
• Abbott (U.S.)
• Medtronic (Ireland)
• Koninklijke Philips N.V. (Netherlands)
• Terumo Corporation (Japan)
• Avinger (U.S.)
• AngioDynamics (U.S.)
• BD (U.S.)

Key Industry Developments

• In March 2024, Xtant Medical publicly announced that it had acquired Avinger to strengthen its position in the cardiovascular device market. More importantly, the acquisition now makes Xtant Medical a holder of Avinger's pioneering atherectomy technologies. Hence, this merger is expected to benefit the company through the enhancement of its market position and product portfolio.
• In February 2024, Medtronic added a collaboration agreement with Biotronik to enhance and elevate its atherectomy device offerings. This collaboration will encompass the amazing recently developed vascular solutions sourced from Biotronik and the open technologies owned by Medtronic. It is expected to broaden patient outcome measures via treatment options available in the market.
• In January 2024, The Ocelot Catheter is an innovative atherectomy device developed by Avinger and released to enhance therapy for peripheral artery disease. Real-time intravascular imaging is embedded within the device to improve accuracy and procedural speed. This advancement solidifies the position of Avinger in the atherectomy devices market.